The role of noncoding RNAs in pituitary adenoma

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Pituitary adenomas (PAs) are prevalent cranial tumors significantly affecting patient quality of life.
• Early detection of PAs is crucial for mitigating clinical complications and improving patient outcomes.
• Noncoding RNAs (ncRNAs), encompassing long noncoding RNA, miRNA, and circRNA, play regulatory roles in gene expression, primarily through translational inhibition.

Purpose of the Study:

• To review the expression patterns of dysregulated ncRNAs implicated in the development of pituitary adenomas.
• To elucidate the potential molecular mechanisms through which aberrant ncRNA expression contributes to PA pathogenesis.

Main Methods:

• Comprehensive literature review of studies investigating noncoding RNA expression in pituitary adenomas.
• Analysis of reported molecular pathways and mechanisms associated with ncRNA dysregulation in PA.

Main Results:

• Dysregulation of various noncoding RNAs (lncRNA, miRNA, circRNA) is consistently observed in pituitary adenomas.
• Altered ncRNA expression patterns are linked to the pathogenesis and progression of PAs.
• Noncoding RNAs represent a promising avenue for the development of novel diagnostic biomarkers for PAs.

Conclusions:

• Understanding the aberrant expression of noncoding RNAs in PAs is vital for biomarker discovery.
• Noncoding RNAs may serve as key regulators in PA development, offering therapeutic targets.
• Further research into ncRNA mechanisms can enhance early detection and management of pituitary adenomas.